Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibitionJeffrey T Mihalic, Pingchen Fan, Xiaoqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Identification of piperazine-bisamide GHSR antagonists for the treatment of obesityMing Yu, Mike Lizarzaburu, Holger Beckmann, et al.
The Journal of Biological Chemistry|January 17, 2009
Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivoAlykhan Motani, Zhulun Wang, Marion Conn, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2014
Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4Yingcai Wang, Richard Connors, Pingchen Fan, et al.
Journal of Molecular Biology|May 20, 2009
INT131: a selective modulator of PPAR gammaAlykhan Motani, Zhulun Wang, Jennifer Weiszmann, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2012
Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetesXiaohui Du, Yong-Jae Kim, Sujen Lai, et al.
JACC. Basic to Translational Science|July 18, 2019
Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial InfarctionWei Wang, Liyan Zhang, Pavan K Battiprolu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
Pageof 2